Myasthenia gravis

Myasthenia gravis is a chronic condition that affects the nervous system, specifically the communication between nerves and muscles. It causes muscle weakness that worsens with activity and improves with rest. The main problem is that the body's immune system mistakenly attacks the receptors that help muscles contract, leading to difficulty in controlling movements. Common symptoms include drooping eyelids, difficulty swallowing, and weakness in the arms and legs. This condition can affect daily activities and overall quality of life by making simple tasks more challenging.

Myasthenia gravis is an autoimmune disorder characterized by antibodies targeting the acetylcholine receptors (AChR) or associated proteins at the neuromuscular junction, leading to impaired synaptic transmission. The most common mechanism involves autoantibodies that block or destroy AChRs, reducing muscle stimulation and causing fluctuating skeletal muscle weakness. It primarily affects voluntary muscles, especially those controlling the eyes, face, and swallowing. The disease is often associated with thymic abnormalities such as thymoma or thymic hyperplasia. Clinically, it presents with fatigable weakness that worsens with exertion and improves with rest, distinguishing it from other neuromuscular disorders. Early diagnosis and management are critical to prevent complications like respiratory failure.